CADL

Candel Therapeutics, Inc.

NasdaqGM · Healthcare

$9.88

+0.30% today

last filing 2026-06-29Pro sees filings in ~15 min

Price

hover · 4 moves explained

1 buy4 sells23 8-K

Analyst consensus

Strong Buy

$19.63target+98.6%vs $9.88 today

$9.00 low today target$29.00 high

8 analysts · ~12-month consensus · as of May 28. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 1 of last 4

Earnings per share · actual vs forecast

Q2 '25-16.6%

−$0.20

exp −$0.17

Q3 '25-37.1%

−$0.23

exp −$0.17

Q4 '25-23.8%

−$0.29

exp −$0.23

Q1 '26+57.1%

−$0.14

exp −$0.33

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Sell	2026-07-01	Barone Francesca	Chief Scientific Officer	—Direct	23,447	$10.06	$235.8K
Sell	2026-07-01	Tyagarajan Seshu	Chief Technology Officer	—Direct	7,000	$10.02	$70.2K
Buy	2026-02-26	Manning Paul B	Director	20%Indirect	550,458	$5.45	$3.00M
Sell	2025-07-30	Nichols William Garrett	Chief Medical Officer	—Direct	937	$6.98	$6.5K
Exercise	2025-07-30	Nichols William Garrett	Chief Medical Officer	—Direct	937	$1.29	$1.2K

Sell

Barone Francesca

Chief Scientific Officer · 2026-07-01

$235.8K

23,447 @ $10.06

Sell

Tyagarajan Seshu

Chief Technology Officer · 2026-07-01

$70.2K

7,000 @ $10.02

Buy

Manning Paul B

Director · 20% of stake · 2026-02-26

$3.00M

550,458 @ $5.45

Sell

Nichols William Garrett

Chief Medical Officer · 2025-07-30

$6.5K

937 @ $6.98

Exercise

Nichols William Garrett

Chief Medical Officer · 2025-07-30

$1.2K

937 @ $1.29

11 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →